In February, 2012, AGI Therapeutics, PLC was acquired by Aravis Limited, a member of the Vidara Therapeutics group of companies. Following the acquisition, on March 2nd, 2012, AGI de-listed from the Alternative Investment Market of the London Stock Exchange (AIM) and the Enterprise Securities Market of the Irish Stock Market (ESM).
If you were previously a shareholder in AGI Therapeutics, plc, and have questions concerning your shareholding, please contact Computershare;
|Phone||353 (1) 4475438||
Computershare Investor Services (Ireland) Limited
Sandyford Industrial Estate